Published in Proc Natl Acad Sci U S A on November 01, 1976
Spliced early mRNAs of simian virus 40. Proc Natl Acad Sci U S A (1978) 18.67
Organization and expression of early genes of simian virus 40. Proc Natl Acad Sci U S A (1978) 7.10
Tumor antigen(s) in cell productively infected by wild-type polyoma virus and mutant NG-18. Proc Natl Acad Sci U S A (1978) 4.64
New region of the simian virus 40 genome required for efficient viral transformation. Proc Natl Acad Sci U S A (1978) 4.24
Physical and genetic characterization of deletion mutants of simian virus 40 constructed in vitro. J Virol (1977) 4.23
Temperature-sensitive growth regulation in one type of transformed rat cells induced by the tsa mutant of polyoma virus. J Virol (1977) 4.07
Virus-specific proteins in the plasma membrane of cells lytically infected or transformed by pol-oma virus. Proc Natl Acad Sci U S A (1977) 3.68
Carboxy terminus of polyoma middle-sized tumor antigen is required for attachment to membranes, associated protein kinase activities, and cell transformation. Proc Natl Acad Sci U S A (1982) 3.12
Physical mapping of herpes simplex virus type 1 mutations by marker rescue. J Virol (1978) 2.86
Comparison of phosphorylation of two polyoma virus middle T antigens in vivo and in vitro. J Virol (1981) 2.85
Variations in polyoma virus genotype in relation to tumor induction in mice. Characterization of wild type strains with widely differing tumor profiles. Am J Pathol (1987) 2.84
New classes of viable deletion mutants in the early region of polyoma virus. J Virol (1979) 2.75
Molecular genetics of herpes simplex virus. VI. Characterization of a temperature-sensitive mutant defective in the expression of all early viral gene products. J Virol (1981) 2.52
Transformation of BALB/c-3T3 cells by tsA mutants of simian virus 40: temperature sensitivity of the transformed phenotype and retransofrmation by wild-type virus. J Virol (1978) 2.42
Construction and analysis of viable deletion mutants of polyoma virus. J Virol (1979) 2.30
Polyomavirus small t antigen: overproduction in bacteria, purification, and utilization for monoclonal and polyclonal antibody production. J Virol (1986) 2.27
Nucleotide sequence deletions within the coding region for small-t antigen of simian virus 40. J Virol (1979) 2.23
Expression of simian virus 40 early genes in transformed rat cells is correlated with maintenance of the transformed phenotype. Proc Natl Acad Sci U S A (1978) 2.01
Viable deletion mutants in the simian virus 40 early region. Proc Natl Acad Sci U S A (1978) 1.89
Polyoma virus middle T antigen: relationship to cell membranes and apparent lack of ATP-binding activity. Mol Cell Biol (1982) 1.87
Effect of alkylation on the physical properties of simian virus 40 T-antigen species. J Virol (1979) 1.77
A single-amino-acid substitution in polyomavirus VP1 correlates with plaque size and hemagglutination behavior. J Virol (1991) 1.77
Middle tumor antigen of polyomavirus transformation-defective mutant NG59 is associated with pp60c-src. J Virol (1985) 1.71
Biological activity of polyoma viral DNA in mice and hamsters. J Virol (1979) 1.70
Measurements of the molecular size of the simian virus 40 large T antigen. J Virol (1978) 1.70
Host range transforming gene of polyoma virus plays a role in virus assembly. Proc Natl Acad Sci U S A (1983) 1.69
Translation of polyoma virus T antigens in vitro. Proc Natl Acad Sci U S A (1978) 1.67
Isolation and characterization of polyoma virus mutants able to develop in embryonal carcinoma cells. Proc Natl Acad Sci U S A (1980) 1.61
Viable deletion mutant in the medium and large T-antigen-coding sequences of the polyoma virus genome. J Virol (1980) 1.60
Coding capacity of a 35 percent fragment of the polyoma virus genome is sufficient to initiate and maintain cellular transformation. Proc Natl Acad Sci U S A (1980) 1.53
Induction and utilization of an ATM signaling pathway by polyomavirus. J Virol (2005) 1.53
Virion assembly defect of polyomavirus hr-t mutants: underphosphorylation of major capsid protein VP1 before viral DNA encapsidation. J Virol (1985) 1.50
Interrupting the early region of polyoma virus DNA enhances tumorigenicity. Proc Natl Acad Sci U S A (1979) 1.45
Polyoma viral middle T-antigen is required for transformation. J Virol (1982) 1.43
Nucleotide sequence of the simian virus 40 small-t gene. Proc Natl Acad Sci U S A (1978) 1.41
Detection of phosphotyrosine-containing proteins in polyomavirus middle tumor antigen-transformed cells after treatment with a phosphotyrosine phosphatase inhibitor. Mol Cell Biol (1987) 1.36
Expression of polyoma early gene products in E. coli. Nucleic Acids Res (1985) 1.29
Homologous recombination between transfected DNAs. Mol Cell Biol (1983) 1.26
Characterization of middle T antigen expressed by using an adenovirus expression system. J Virol (1987) 1.25
Nucleotide sequence changes in polyoma virus A gene mutants. J Virol (1981) 1.19
Polyoma virus. The early region and its T-antigens. Nucleic Acids Res (1979) 1.18
Abundant expression of polyomavirus middle T antigen and dihydrofolate reductase in an adenovirus recombinant. J Virol (1987) 1.15
Requirement for the C-terminal region of middle T-antigen in cellular transformation by polyoma virus. Nucleic Acids Res (1981) 1.10
Different roles for two enhancer domains in the organ- and age-specific pattern of polyomavirus replication in the mouse. Mol Cell Biol (1992) 1.06
Deletion mutants of polyoma virus defining a nonessential region between the origin of replication and the initiation codon for early proteins. J Virol (1979) 1.06
Phosphorylation of polyomavirus large T antigen: effects of viral mutations and cell growth state. J Virol (1987) 1.05
Polyoma large tumor antigen is not required for tumorigenesis mediated by viral DNA. Proc Natl Acad Sci U S A (1980) 1.04
Large-scale production of polyoma middle T antigen by using genetically engineered tumors. Mol Cell Biol (1985) 1.03
Isolation and characterization of polyoma virus genomes with deletions between the origin of viral DNA replication and the site of initiation of translation in the early region. J Virol (1979) 0.99
Initiation of polyoma virus DNA replication in vitro and its dependence on the viral gene A protein. Nucleic Acids Res (1980) 0.97
A cloned polyoma DNA fragment representing the 5' half of the early gene region is oncogenic. J Virol (1980) 0.96
Localization of the phosphorylations of polyomavirus large T antigen. J Virol (1987) 0.94
Enhancer-mediated role for polyomavirus middle T/small T in DNA replication. J Virol (1995) 0.91
Inositol trisphosphate levels in cells expressing wild-type and mutant polyomavirus middle T antigens: evidence for activation of phospholipase C via activation of pp60c-src. J Virol (1990) 0.90
Virion assembly factories in the nucleus of polyomavirus-infected cells. PLoS Pathog (2012) 0.89
Polyoma virus mutant with normal transforming ability but impaired tumorigenic potential. J Virol (1982) 0.89
Measurements of the genome sizes of simian virus 40 and polyoma virus. J Virol (1977) 0.87
Phosphorylation of polyoma middle T antigen and cellular proteins in purified plasma membranes of polyoma virus-infected cells. EMBO J (1985) 0.87
Role of middle T-small T in the lytic cycle of polyomavirus: control of the early-to-late transcriptional switch and viral DNA replication. J Virol (2001) 0.86
Induction and bypass of p53 during productive infection by polyomavirus. J Virol (2002) 0.85
Phosphatidylinositol 3-kinase binding to polyoma virus middle tumor antigen mediates elevation of glucose transport by increasing translocation of the GLUT1 transporter. Proc Natl Acad Sci U S A (1995) 0.85
A nonlethal mutation in large T antigen of polyomavirus which affects viral DNA synthesis. J Virol (1989) 0.85
Viral DNA synthesis in nonpermissive rat F-111 cells and its role in neoplastic transformation by polyomavirus. Mol Cell Biol (1989) 0.84
DNA synthesis and template activity in a mutant of polyoma virus with altered expression of late viral proteins. J Virol (1981) 0.80
Polyomavirus middle T antigen induces ribosomal protein S6 phosphorylation through pp60c-src-dependent and -independent pathways. Mol Cell Biol (1988) 0.80
Structural and Functional Analysis of Murine Polyomavirus Capsid Proteins Establish the Determinants of Ligand Recognition and Pathogenicity. PLoS Pathog (2015) 0.79
Mutation affecting late gene expression in polyoma virus maps in the late region. J Virol (1982) 0.78
Species-specific cellular DNA-binding proteins expressed in mouse cells transformed by chemical carcinogens. Proc Natl Acad Sci U S A (1978) 0.75
BALB/3T3 cells infected by the ts3 mutant of polyoma virus fail to accumulate virus-specific early RNA at the nonpermissive temperature. J Virol (1977) 0.75
Activation of DNA damage repair pathways by murine polyomavirus. Virology (2016) 0.75
Low probability of double integration in transformation of nonpermissive cells by polyomavirus. J Virol (1990) 0.75
Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol (1967) 106.91
Detection of two restriction endonuclease activities in Haemophilus parainfluenzae using analytical agarose--ethidium bromide electrophoresis. Biochemistry (1973) 43.61
AGAR SUSPENSION CULTURE FOR THE SELECTIVE ASSAY OF CELLS TRANSFORMED BY POLYOMA VIRUS. Virology (1964) 14.14
Construction and analysis of viable deletion mutants of simian virus 40. J Virol (1976) 9.11
Complementation and transformation by temperature-sensitive mutants of polyoma virus. Virology (1969) 6.04
Host range mutants of polyoma virus. Proc Natl Acad Sci U S A (1970) 5.68
A map of temperature-sensitive mutants of simian virus 40. Virology (1975) 4.77
Temperature-sensitive mutants of polyoma virus. Virology (1969) 4.45
Mapping temperature-sensitive mutants of simian virus 40: rescue of mutants by fragments of viral DNA. Virology (1974) 4.30
Genetic assay for small fragments of bacteriophage phi X174 deoxyribonucleic acid. J Virol (1971) 3.78
Molecular cloning of DNA fragments produced by restriction endonucleases Sa1I and BamI. Proc Natl Acad Sci U S A (1976) 3.32
Virus-specific RNA in cells productively infected or transformed by polyoma virus. Cold Spring Harb Symp Quant Biol (1975) 3.06
Construction of the genetic map of the polyoma genome. J Virol (1976) 2.49
Deficiency in histone acetylation in nontransforming host range mutants of polyoma virus. Proc Natl Acad Sci U S A (1976) 2.37
Analysis of host range of nontransforming polyoma virus mutants. Virology (1975) 2.18
Polyoma T antigen synthesis by temperature-sensitive mutants of polyoma virus. Virology (1972) 1.84
Polyoma virus T antigen. I. Synthesis of modified heat-labile T angiten in cells transformed with the ts-a mutant. J Virol (1975) 1.82
Construction of infectious polyoma hybrid genomes in vitro. Nature (1976) 1.77
SV40 DNA: quantitative conversion of closed circular to open circular form by an ethidium bromide-restricted endonuclease. J Mol Biol (1973) 1.51
Genetics of DNA tumor viruses. Annu Rev Genet (1974) 1.23
Properties of the ts3 mutant of polyoma virus during lytic infection. Virology (1974) 1.23
Mapping simian virus 40 mutants by construction of partial heterozygotes. J Virol (1975) 1.22
Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell (1997) 8.28
Familial breast-ovarian cancer locus on chromosome 17q12-q23. Lancet (1991) 6.61
Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell (1997) 5.92
Tumor antigens induced by nontransforming mutants of polyoma virus. Cell (1978) 2.92
PML induces a novel caspase-independent death process. Nat Genet (1998) 2.66
Autorepressor model for control of DNA replication. Nat New Biol (1973) 2.52
P53 germline mutations in childhood cancers and cancer risk for carrier individuals. Br J Cancer (2000) 2.35
Increasing incidence of breast cancer in family with BRCA1 mutation. Lancet (1993) 2.33
Nucleotide sequence deletions within the coding region for small-t antigen of simian virus 40. J Virol (1979) 2.23
DNA screening for breast/ovarian cancer susceptibility based on linked markers. A family study. Arch Intern Med (1993) 1.91
Viable deletion mutants in the simian virus 40 early region. Proc Natl Acad Sci U S A (1978) 1.89
Location of BRCA1 in human breast and ovarian cancer cells. Science (1996) 1.88
Immortalization of rodent embryo fibroblasts by SV40 is maintained by the A gene. Virology (1983) 1.87
Radiation and genetic factors in the risk of second malignant neoplasms after a first cancer in childhood. Lancet (1997) 1.84
Sensitivity and predictive value of criteria for p53 germline mutation screening. J Med Genet (2001) 1.77
Defect in entry and altered pathogenicity of a polyoma virus mutant blocked in VP2 myristylation. Virology (1993) 1.51
A new member of the polyomavirus family: the hamster papovavirus. Complete nucleotide sequence and transformation properties. EMBO J (1985) 1.50
A 1-kb Alu-mediated germ-line deletion removing BRCA1 exon 17. Cancer Res (1997) 1.49
A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families. Am J Hum Genet (1996) 1.45
ARCAD: a method for estimating age-dependent disease risk associated with mutation carrier status from family data. Genet Epidemiol (1995) 1.37
Study of the maturation of 5 s RNA precursors in Escherichia coli. J Mol Biol (1972) 1.37
BRCA1 and BRCA2 are necessary for the transcription-coupled repair of the oxidative 8-oxoguanine lesion in human cells. Cancer Res (2000) 1.36
Roles of N-glycans with alpha2,6 as well as alpha2,3 linked sialic acid in infection by polyoma virus. Virology (1997) 1.26
A ribonuclease-resistant region of 5S RNA and its relation to the RNA binding sites of proteins L18 and L25. Nucleic Acids Res (1979) 1.22
Genetic mapping of the breast-ovarian cancer syndrome to a small interval on chromosome 17q12-21: exclusion of candidate genes EDH17B2 and RARA. Hum Mol Genet (1993) 1.19
Simian virus 40 deletion mutants that transform with reduced efficiency. Mol Cell Biol (1983) 1.12
The influence of the reading context upon the suppression of nonsense codons. 3. Cold Spring Harb Symp Quant Biol (1969) 1.11
Abnormalities of the inactive X chromosome are a common feature of BRCA1 mutant and sporadic basal-like breast cancer. Cold Spring Harb Symp Quant Biol (2005) 1.10
Gamma-rays-induced death of human cells carrying mutations of BRCA1 or BRCA2. Oncogene (1999) 1.07
Overexpression of MDM2, due to enhanced translation, results in inactivation of wild-type p53 in Burkitt's lymphoma cells. Oncogene (1998) 1.06
Stable cell line of T-SV40 immortalized human glomerular visceral epithelial cells. Kidney Int (1991) 1.04
A simian virus 40 dl884/tsA58 double mutant is temperature sensitive for abortive transformation. J Virol (1983) 1.04
A Thermosensitive mutant defective in ribosomal 30 S subunit assembly. FEBS Lett (1971) 1.03
Polyoma tumorigenesis in mice: evidence for dominant resistance and dominant susceptibility genes of the host. Virology (1992) 1.03
Phosphorylation pattern of large T antigens in mouse cells infected by simian virus 40 wild type or deletion mutants. J Virol (1982) 1.01
Mutant carrying deletions in the two simian virus 40 early genes. J Virol (1981) 1.00
Development of medullary thyroid carcinoma in transgenic mice expressing the RET protooncogene altered by a multiple endocrine neoplasia type 2A mutation. Proc Natl Acad Sci U S A (1997) 1.00
Induction of lymphomas by the hamster papovavirus correlates with massive replication of nonrandomly deleted extrachromosomal viral genomes. J Virol (1987) 0.99
Stable cell lines of T-SV40 immortalized human glomerular mesangial cells. Kidney Int (1996) 0.99
Tumor induction by a transformation-defective polyoma virus mutant blocked in signaling through Shc. Proc Natl Acad Sci U S A (1997) 0.98
Abnormal maturation of precursor 16S RNA in a ribosomal assembly defective mutant of E. coli. Nucleic Acids Res (1974) 0.98
Combination chemotherapy with or without s.c. IL-2 and IFN-alpha: results of a prospectively randomized trial of the Cooperative Advanced Malignant Melanoma Chemoimmunotherapy Group (ACIMM). Br J Cancer (2002) 0.97
The gene for hereditary breast-ovarian cancer, BRCA1, maps distal to EDH17B2 in chromosome region 17q12-q21. Hum Mol Genet (1994) 0.96
p53 compound heterozygosity in a severely affected child with Li-Fraumeni syndrome. Oncogene (1999) 0.96
Identification and characterization of the hamster polyomavirus middle T antigen. J Virol (1991) 0.96
Model SV40-transformed fibroblast lines for metabolic studies of human prosaposin and acid ceramidase deficiencies. Clin Chim Acta (1997) 0.95
Ribosomal assembly defective mutants of Escherichia coli. Nucleic Acids Res (1974) 0.95
Oncogenic potential of guanine nucleotide stimulatory factor alpha subunit in thyroid glands of transgenic mice. Proc Natl Acad Sci U S A (1994) 0.95
The hamster polyomavirus--a brief review of recent knowledge. Virus Genes (2001) 0.95
The simian virus 40 sequences between 0.169 and 0.423 map units are not essential to immortalize early-passage rat embryo cells. Mol Cell Biol (1985) 0.94
5 S RNA and the assembly of bacterial ribosomes. Cold Spring Harb Symp Quant Biol (1969) 0.93
Thyroid pathologies in transgenic mice expressing a human activated Ras gene driven by a thyroglobulin promoter. Oncogene (1996) 0.92
Resistance of MCF7 human breast carcinoma cells to TNF-induced cell death is associated with loss of p53 function. Oncogene (1997) 0.92
Isolation of transformation-defective host-range mutants of polyoma virus on normal mouse cells. Virology (1982) 0.92
[Li-Fraumeni syndrome: update, new data and guidelines for clinical management]. Bull Cancer (2001) 0.92
Identification of gel-separated tumor marker proteins by mass spectrometry. Electrophoresis (2000) 0.91
Less than 40% of the simian virus 40 large T-antigen-coding sequence is required for transformation. Mol Cell Biol (1984) 0.90
Prereplicative events involving simian virus 40 DNA in permissive cells. J Virol (1982) 0.90
Analysis of the hamster polyomavirus infection in vitro: host-restricted productive cycle. Virology (1990) 0.90
Germ-line exclusion of a single p53 allele by premature termination of translation in a Li-Fraumeni syndrome family. Oncogene (1994) 0.89
BRCA1 carries tumor suppressor activity distinct from that of p53 and p21. Cancer Gene Ther (2001) 0.89
Influence of amino acids encoded in the 3' open reading frame of the SV40 early region on transformation and antigenicity of large T antigen. Virology (1986) 0.89
Histology of BRCA1-associated ovarian tumours. Lancet (1994) 0.89
The hamster polyomavirus transforming properties. Oncogene (1988) 0.89
Molecular characterization and sequencing of antifreeze proteins from larvae of the beetle Dendroides canadensis. J Comp Physiol B (1998) 0.88
An SV40 mutant T antigen does not bind the SV40 viral origin. Virology (1986) 0.88
Isolation of renin-producing human cells by transfection with three simian virus 40 mutants. Proc Natl Acad Sci U S A (1985) 0.87
Measurements of the genome sizes of simian virus 40 and polyoma virus. J Virol (1977) 0.87
Genetic transmission of susceptibility to cancer in families of children with soft tissue sarcomas. Cancer (1996) 0.87
SV40 induced cellular immortalization: phenotypic changes associated with the loss of proliferative capacity in a conditionally immortalized cell line. Oncogene (1990) 0.85
Counting and cardinal understanding in children with Down syndrome and typically developing children. Downs Syndr Res Pract (2001) 0.85
Sequential analysis of chemically induced hepatoma development in rats by two dimensional electrophoresis. Cancer Res (1986) 0.85
Cellular and C-type viral factors in infections by polyoma virus hr-t mutants. Virology (1979) 0.84
Intracellular morphogenesis of bacteriophage T4. I. Gene dosage effects on early functions and tail fiber assembly. Virology (1984) 0.84
SV40-immortalization of rabbit articular chondrocytes: alteration of differentiated functions. J Cell Physiol (1992) 0.84
Apoptosis is antagonized by large T antigens in the pathway to immortalization by polyomaviruses. Oncogene (1994) 0.84
A 100-kb physical and transcriptional map around the EDH17B2 gene: identification of three novel genes and a pseudogene of a human homologue of the rat PRL-1 tyrosine phosphatase. Hum Genet (1995) 0.83
Early gene expression in lymphoma-associated hamster polyomavirus viral genomes. Oncogene (1992) 0.83
Expression of proto-oncogenes in normal and papovavirus-transformed or -infected rat fibroblasts. Virology (1985) 0.83
Induced mutagenesis of Simian virus 40 in carcinogen-treated monkey cells. Basic Life Sci (1983) 0.82
The tumor suppressor activity induced by adenovirus-mediated BRCA1 overexpression is not restricted to breast cancers. Gene Ther (2006) 0.82
Familial transmission of 16p trisomy in an infant. Hum Genet (1989) 0.82
Transformation by hamster polyomavirus: identification and functional analysis of the early genes. J Virol (1992) 0.81
Micropreparative immobilized pH gradient two-dimensional electrophoresis in combination with protein microsequencing for the analysis of human liver proteins. Electrophoresis (1995) 0.81
The SV40 T-antigen gene can have two introns. Virology (1985) 0.81
Infection by polyomavirus of murine cells deficient in class I major histocompatibility complex expression. J Virol (1992) 0.81
Hereditary breast cancer and family cancer syndromes. World J Surg (1994) 0.81
Comparison of the metabolism of 2,4-toluenediamine in rats and mice. J Environ Pathol Toxicol (1979) 0.81
Studies on the DNA of an oncogenic papovavirus of the Syrian hamster. Virology (1979) 0.81
Reversibility of the transformed and neoplastic phenotype. IV. Effects of long-term interferon treatment of C3H/10T1/2 cells transformed by methylcholanthrene and SV40 virus. Int J Cancer (1984) 0.81
The gene for mannose-binding protein maps to chromosome 10 and is a marker for multiple endocrine neoplasia type 2. Cytogenet Cell Genet (1991) 0.80
Episomal amplification or chromosomal integration of the viral genome: alternative pathways in hamster polyomavirus-induced lymphomas. J Virol (1995) 0.80
Viral genomes maintained extrachromosomally in hamster polyomavirus-induced lymphomas display a cell-specific replication in vitro. J Virol (1993) 0.80
Kinetic analysis of the steps of the polyomavirus lytic cycle. J Virol (2001) 0.79
A simple method for screening for Farber disease on cultured skin fibroblasts. Clin Chim Acta (1996) 0.79
Transfer of immortality by transfection of genomic DNA from SV40 established cell lines into rat embryo fibroblasts. Biol Cell (1990) 0.79
Mutations within the hamster polyomavirus large T antigen domain involved in pRb binding impair virus productive cycle and immortalization capacity. Oncogene (1993) 0.79
An improved electrotransfection method using square shaped electric impulsions. Biochem Biophys Res Commun (1988) 0.79
In vivo replication of the hamster polyomavirus genome and generation of specific deletions in the process of lymphomagenesis. J Virol (1994) 0.78
Enzymic N-acetylation of 2,4-toluenediamine by liver cytosols from various species. Xenobiotica (1975) 0.78